Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1430

Benzinga · 5d ago
Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1419 to $1430.